Clinical Trials Browser

Phase 2 × Adenocarcinoma of Lung × Immune Checkpoint Inhibitors × Clear all

NCT04459078 2022-12-02

Clinical Study of Camrelizumab Combined With APatinib and Albumin Paclitacxel in Patients With Advanced Lung Adenocarcinoma

Phase 2 Unknown

Adenocarcinoma of Lung